An article written by GlyTech’s CEO Hiroaki Asai and Dr. Izumi Sakamoto was published in the 31th issue of PHARM TECH JAPAN (No. 1, p119-121).

An article “Oligosaccharide structures and Biopharmaceuticals Part 1” written by GlyTech’s Hiroaki Asai and Izumi Sakamoto was published in the 30th issue of PHARMA TECH JAPAN. PHARM TECH JAPAN is known for presenting on the latest ideas, cutting-edge technologies and innovationas covering not only drug manufacturing but also the regulatory issues.

Last updated:

Back to index of news